PAVPavmed's Digital Health Subsidiary Veris Health Has Been Awarded A $1.8M Grant From The National Institute On Minority Health And Health Disparities, The Two-year Grant Will Fund Research To Optimize And Validate The Veris Cancer Care Platform
Portfolio Pulse from Benzinga Newsdesk
PAVmed's subsidiary, Veris Health, received a $1.8M grant from the National Institute on Minority Health and Health Disparities to enhance its Veris Cancer Care Platform. This funding will support research over two years.
October 10, 2024 | 11:56 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
PAVmed's subsidiary, Veris Health, has been awarded a $1.8M grant to optimize its Cancer Care Platform, potentially boosting PAVmed's innovation and revenue prospects.
The $1.8M grant will fund research to optimize Veris Health's Cancer Care Platform, which could lead to improved product offerings and increased revenue for PAVmed. This positive development is likely to enhance investor sentiment and drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 80